::Artisan Pharma:: News






Artisan Pharma, Inc. Completes Enrollment in 750-patient Phase 2b Study of ART-123 in Sepsis Patients with DIC Artisan Pharma Raises $22 Million Series B Financing Artisan Pharma Appoints Gary Shearman Executive Chairman Artisan Pharma’s Lead Product, ART-123, Approved in Japan Gary Shearman Ph.D. Joins Board of Artisan Pharma, Inc. Artisan Pharma, Inc. And A-Bio Pharma Pte Ltd. Announce Strategic Manufacturing Alliance on ART-123 Artisan Pharma, Inc. Launches Phase 2b Trial of ART-123 for Treatment of DIC in Sepsis Artisan Corporate Overview ( pdf ) Boston Business Journal News & Info As Artisan Pharma continues to make progress in corporate and product development, please check back here for the latest press releases, details on speaking and conference appearances, publications and more. 29 April, 2010 Artisan Pharma, Inc. Completes Enrollment in 750-patient Phase 2b Study of ART-123 in Sepsis Patients with DIC 01 March,2010 Artisan Pharma Raises $22 Million Series B Financing 4 January, 2010 Artisan Pharma Appoints Gary Shearman Executive Chairman 22 February, 2008 Artisan Pharma’s Lead Product, ART-123, Approved in Japan 22 October, 2007 Gary Shearman Ph.D. Joins Board of Artisan Pharma, Inc. 18 September, 2007 Artisan Pharma, Inc. And A-Bio Pharma Pte Ltd. Announce Strategic Manufacturing Alliance on ART-123 21 August, 2007 Artisan Pharma, Inc. Launches Phase 2b Trial of ART-123 for Treatment of DIC in Sepsis 19 February, 2007 Artisan Pharma to present at The Atlas Venture Japan Biopharma Partnering Conference 2007, co-sponsored by Itochu Corp., NIF SMBC Ventures Co. Ltd., Dechert LLP and EBD Group on March 20, 2007 in Tokyo, Japan 19 February, 2007 Artisan Pharma to present at BIO-Asia Conference on January 29, 2007 in Tokyo, Japan 10 November, 2006 Artisan to present at JAFCO BioConference 2006 on November 14, 2006 in Tokyo, Japan 6 September, 2006 Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC Artisan Corporate Overview ( pdf )